Cargando…
Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
OBJECTIVES: The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national he...
Autores principales: | Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066703/ https://www.ncbi.nlm.nih.gov/pubmed/27785081 http://dx.doi.org/10.2147/CEOR.S107831 |
Ejemplares similares
-
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
por: Athanasakis, Kostas, et al.
Publicado: (2013) -
Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals
por: Athanasakis, Kostas, et al.
Publicado: (2014) -
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
por: Ademi, Zanfina, et al.
Publicado: (2016) -
Evaluation of the Quality of Life of Patients with Myasthenia Gravis in Greece
por: Aggelina, Afrodite, et al.
Publicado: (2023) -
Barriers in access to healthcare services for chronic patients in times of austerity: an empirical approach in Greece
por: Kyriopoulos, Ilias-Ioannis, et al.
Publicado: (2014)